Harel Insurance Investments & Financial Services Ltd. Buys 242 Shares of Xylem Inc. (NYSE:XYL)

Harel Insurance Investments & Financial Services Ltd. boosted its stake in Xylem Inc. (NYSE:XYL) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,404 shares of the industrial products company’s stock after purchasing an additional 242 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in Xylem were worth $326,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. First Pacific Financial raised its position in shares of Xylem by 1.6% during the 2nd quarter. First Pacific Financial now owns 7,435 shares of the industrial products company’s stock valued at $1,008,000 after buying an additional 119 shares in the last quarter. Hennion & Walsh Asset Management Inc. purchased a new stake in Xylem during the second quarter valued at about $344,000. Raymond James & Associates raised its position in Xylem by 7.7% during the second quarter. Raymond James & Associates now owns 121,776 shares of the industrial products company’s stock valued at $16,517,000 after purchasing an additional 8,721 shares in the last quarter. OFI Invest Asset Management lifted its stake in Xylem by 7.0% during the second quarter. OFI Invest Asset Management now owns 227,640 shares of the industrial products company’s stock worth $28,808,000 after purchasing an additional 14,909 shares during the last quarter. Finally, TCW Group Inc. boosted its holdings in shares of Xylem by 189.2% in the 2nd quarter. TCW Group Inc. now owns 315,400 shares of the industrial products company’s stock worth $42,778,000 after purchasing an additional 206,350 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Trading Down 0.5 %

Shares of NYSE:XYL traded down $0.70 during midday trading on Tuesday, hitting $133.68. 232,434 shares of the stock traded hands, compared to its average volume of 1,211,540. The company has a quick ratio of 1.33, a current ratio of 1.85 and a debt-to-equity ratio of 0.19. The business’s 50 day moving average is $135.42 and its two-hundred day moving average is $132.66. The stock has a market capitalization of $32.47 billion, a PE ratio of 47.49, a P/E/G ratio of 2.34 and a beta of 1.04. Xylem Inc. has a one year low of $87.59 and a one year high of $146.08.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. Xylem had a return on equity of 9.48% and a net margin of 9.11%. The company had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter in the previous year, the business earned $0.98 EPS. Xylem’s revenue was up 26.0% compared to the same quarter last year. As a group, research analysts forecast that Xylem Inc. will post 4.25 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 26th. Investors of record on Thursday, August 29th will be issued a dividend of $0.36 per share. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.08%. Xylem’s dividend payout ratio is presently 51.25%.

Wall Street Analyst Weigh In

XYL has been the topic of a number of research reports. Argus boosted their target price on Xylem from $146.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, May 29th. Royal Bank of Canada lifted their price target on shares of Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 31st. Mizuho upped their price objective on shares of Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a research note on Friday, May 3rd. Oppenheimer increased their target price on shares of Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a report on Friday, May 31st. Finally, TD Cowen boosted their price target on shares of Xylem from $135.00 to $138.00 and gave the stock a “buy” rating in a research note on Thursday, June 6th. Five analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $147.54.

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the transaction, the senior vice president now owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of Xylem stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now owns 3,536 shares in the company, valued at $490,195.68. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.